H2 receptor blocker, also known as H2 receptor antagonist, is a class of drugs mostly used to treat and inhibit duodenal ulcers. Additionally, it is used for the treatment of gastric ulcers and for conditions such as Zollinger-Ellison disease, in which excessive acid is secreted by the stomach. H2 receptor effectively works to reduce acid reflux or GERD (gastro-esophageal reflux disease). These drugs are available as over the counter (OTC) as well as with registered medical prescription.
The global H2-receptor blocker market is segmented on the basis of drug class, dosage form, application, and distribution channel. Based on the drug class, the market is segmented into famotidine, cimetidine, ranitidine, and nizatidine which are all widely used medicines as H2- receptor antagonist. Based on the dosage form, the market is segmented into tablet, powder, suspension, and syrup. Depending on application, the H2- receptor blocker market is segmented into gastritis, peptic ulcers, Zollinger-Ellison Syndrome, allergies and acid reflux agents. Based on the distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies.
To Request a Sample of our Report on Global H2 receptor Blocker Market: https://www.omrglobal.com/request-sample/h2-receptor-blocker-market
Major drivers associated with global H2 receptor blocker market include rising prevalence and rising incidence of medical conditions such as inflamed stomach, gastro-esopheagal reflux disease, duodenal and gastric ulcers Additionally, the factor contributing to significant growth of the global H2 receptor blocker market is the increasing number of generic manufacturers for drugs. Rising prevalence of peptic ulcer and stress induced ulcer due to changes in diet and day to day lifestyle may increase the demand for H2-receptor antagonist which is anticipated to enhance the growth of global market.
To propel the market growth during the forecast period, the major strategy acquired by H2-receptor blocker market players include to focus on R&D of the product portfolio. To meet the increasing demand of market and deliver high-quality, non-adulterated drugs with improved dosage form and assemble innovative techniques owing to the sequential expansion of global H2 receptor blocker market.
Market Coverage
· The market number available for – 2020-2027
· Base year- 2020
· Forecast period- 2021-2027
· Segment Covered-
· By Drug Class
· By Dosage Form
· By Application
· By Distribution Channel
· Competitive Landscape- GSK, Medochemie, Horizon Pharma, ZAFA Pharmaceutical, Merck, Incepta Pharmaceuticals Ltd., Brotannica.
(Get 15% Discount on Buying this Report)
A full Report of Global H2 receptor Blocker Market is Available at: https://www.omrglobal.com/industry-reports/h2-receptor-blocker-market
Global H2 Receptor Blocker Market Report Segments
By Drug Class
· Famotidine
· Cimetidine
· Ranitidine
· Nizatidine
By Dosage Form
· Tablet
· Powder
· Syrup
· Suspension
· Others
By Application
· Gastritis
· Peptic Ulcers
· Zollinger-Ellison Syndrome
· Allergies
· Others
By Distribution Channel
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
